Stock screenerAll disclosures →
EDGAR →
CELU
Conviction 20HealthcareScan · Fri, Jun 26, 2026CELU$0.6299-5.32%
ResistanceSupportVol 14Vol MA14 277.29K
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price0.6299
Change-5.32%
Gap-10.52%
Rel volume10.74×
Avg volume228.82K
Avg $ vol169.65K
SMA 200.8113
SMA 500.9009
SMA 2001.42
Price vs 50-30.08%
Price vs 200-55.49%
MA stackbearish
50/200 cross—
Supertrenddown · 0.9063
RSI (14)33
MACD hist-0.01
MACD cross—
Stoch %K / %D15 / 12
ADX (14)19
+DI / −DI17 / 26
RSI divergenceBullish
MACD divergenceBullish
ATR %+15.29%
ADR %13.07%
52w high4.15
52w low0.6299
From 52w high-84.82%
Above 52w low+0.00%
New 52w highNo
SqueezeOff
Bollinger width68.08%
%B0.17
Donchian pos11.41%
Donchian high1.08
Donchian low0.5726
AVWAP (52w high)1.64
vs AVWAP high-61.57%
AVWAP (52w low)0.6208
vs AVWAP low+1.46%
OBV trendDown
Chaikin MF (20)-0.06
Today vs 20d10.74×
Avg vol (14d)277.29K
Avg vol (20d)228.82K
Avg $ vol (20d)169.65K
Market cap—
RS 3m (vs SPY)-56.81%
RS 6m (vs SPY)-56.82%
RS line new highNo
Trend template0/8
Technical rank4.4
1 week-16.27%
1 month-31.17%
3 months-47.51%
6 months-51.17%
1 year-66.49%
YTD-47.94%
P/E-0.21
P/B-0.51
P/S0.73
P/FCF-1.44
EPS-3.59
Div yield—
ROE240.96%
ROA-85.45%
Debt/Eq-0.61
Current0.15
EV/EBITDA-0.67
Gross margin25.44%
Net margin-345.45%
Rev growth-51.03%
EPS growth-58.43%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value36.45M
Revenue5.28M
Net income-23.08M
Gross profit184K
Free cash flow-13.41M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out28.95M
Employees115
ListedMon, Jul 19, 2021
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction20 / 100
Pattern quality—
Tech rank4.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.07
Support0.6885
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Sep 30, 2025 · quarterly.
Congress activity
Disclosed STOCK Act trades in CELU
No recent disclosed trades by Congress in CELU. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CELU · 3 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Brigido Stephen Pres., Functional Regeneration · Class A Common Stock · 2026-04-13 | Tax | 268 | $343 | 2026-04-13 | 2026-04-15 |
Brigido Stephen Pres., Functional Regeneration · Class A Common Stock · 2026-04-13 | Exercise | 821 | $0 | 2026-04-13 | 2026-04-15 |
Hariri Robert J Chief Executive Officer · Restricted Stock Units · 2026-04-13 | Exercise | 3.28K | $0 | 2026-04-13 | 2026-04-15 |
Hariri Robert J Chief Executive Officer · Class A Common Stock · 2026-04-13 | Exercise | 3.28K | $0 | 2026-04-13 | 2026-04-15 |
Brigido Stephen Pres., Functional Regeneration · Restricted Stock Units · 2026-04-13 | Exercise | 821 | $0 | 2026-04-13 | 2026-04-15 |
Haines John R Senior Exec Vice President · Class A Common Stock · 2026-04-13 | Tax | 583 | $746 | 2026-04-13 | 2026-04-15 |
Haines John R Senior Exec Vice President · Class A Common Stock · 2026-04-13 | Exercise | 1.64K | $0 | 2026-04-13 | 2026-04-15 |
Haines John R Senior Exec Vice President · Restricted Stock Units · 2026-04-13 | Exercise | 1.64K | $0 | 2026-04-13 | 2026-04-15 |
Hariri Robert J Chief Executive Officer · Class A Common Stock · 2026-04-13 | Tax | 1.18K | $2K | 2026-04-13 | 2026-04-15 |
SEC filings
EDGAR filings in CELU · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.